6/24/2022At ASCO 2022, Chinese Biotech Firms Deliver Rosy Data On PD-(L)1, Cell...

6/23/2022Sino Biopharmaceutical to Acquire F-Star Therapeutics for $161M

6/23/2022NMPA Announces Package Insert Revision of Glucosamine Formulations

6/23/2022Deloitte Maps Out Four Likely Scenarios for China's Health Ecosystem i...

6/22/2022China's Mental-health Crisis Is Getting Worse (Economist)

6/21/2022China's May Fundraising Indicates Interest in Early-stage Biotech

6/21/2022Xuanzhu Biopharma Out-licenses Greater China Rights of Two Anti-infect...

6/21/2022Innovent and Lilly Jointly Announce Chinese Approval of TYVYT Combo wi...

6/21/2022JPO Issues Bidding Documents for the 7th Round of Volume-Based Procure...

6/21/2022AstraZeneca to Open New Regional Headquarters in Qingdao

6/18/2022Understanding China's Internet Healthcare and Opportunities for Invest...

6/16/2022Pharma Downplays Challenges, Seeing Innovation Instead (Biospace)

6/16/2022May Approvals Spotlight the Rise of Pediatric Drugs under Policy Suppo...

6/16/2022WuXi ATU and Wugen Form Manufacturing Partnership for Novel Cell Cance...

6/15/2022Data Snapshot: Competitive Landscape of Chinese Biosimilars

6/15/2022NMPA Holds Forum to Hear Feedbacks from Pharma MNCs

6/15/2022NHSA Releases the Draft Working Plan and the Application Guide for Adj...

6/14/2022IQVIA: Chinese Retail Pharmacy Sales Down 1.2% in Q1/2022

6/14/2022NHSA Publishes 2021 National Basic Medical Insurance Sector Developmen...

6/14/2022Pharma Giants Turn to Incubators to Tap Chinese Innovation and Hatch S...

6/14/2022FDA's Treatment of China-Developed Drugs Spurs Demands for Multiregion...

6/10/2022Delisting Risk, Souring Relations Are Hurdles for Chinese Biotech Firm...

6/10/2022NHC and SATCM Issue the Rules for Internet Diagnosis and Treatment Reg...

6/9/2022OnCusp and Multitude Enter into an Ex-China Licensing Agreement for a ...

6/7/2022Nicholas Hall Group: Performance of China's Consumer Healthcare Market...

6/7/2022NH's DB6: Top Ten Chinese CHC Brands in 2021

6/7/2022NH's DB6: Chinese OTC Drug Market Forecast 2026/2031

6/7/2022Fosun Pharma Acquires 60% of Singapore OncoCare Medical for $158M

6/7/2022China Issues the Notice on Correction of Irregularities in Drug Procur...

6/7/2022How Shanghai Kept Clinical Trials Going During Lockdown (PharmaDJ)

Page:70/361 Total number of articles:10826: [First][<<] [68] [69] [70] [71] [72] [>>] [End]